⌘K

Home/Filings/4/0001493152-24-049432

4//SEC Filing

Alteral Therapeutics ApS 4

Accession 0001493152-24-049432

CIK 0001011060other

View on SEC.gov Company Profile

Filed

Dec 9, 7:00 PM ET

Accepted

Dec 10, 2:04 PM ET

Size

5.3 KB

Accession

0001493152-24-049432

Insider Transaction Report

Form 4

Period: 2024-11-12

Nordicus Partners CorpNORD

Alteral Therapeutics ApS

10% Owner

Transactions

Other
Common stock
2024-11-12+4,030,903→ 5,296,131 total

Footnotes (1)

[F1]Shares acquired in connection with the acquisition by Nordicus Partners Corporation through a share exchange with the shareholders of Bio-Convert ApS on November 12, 2024.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Nordicus Partners Corp

CIK 0001011060

Entity typeother

IncorporatedDenmark

Related Parties

1

filerCIK 0002026040

Filing Metadata

Form type: 4
Filed: Dec 9, 7:00 PM ET
Accepted: Dec 10, 2:04 PM ET
Size: 5.3 KB

View on SEC.gov